Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,110.00    -20.00 (-0.28%)
Bid:
7,105.00
Ask:
7,115.00
Spread: 10.00 (0.141%)
Market Cap: £9.53b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

30 Mar 2015 07:00

RNS Number : 7560I
Diploma PLC
30 March 2015
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

30 March 2015

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update for the six months ending 31 March 2015, ahead of going into its close period.

 

Trading Summary

The businesses acquired during the past year have made a good contribution to the Group's overall results and revenues for the six months ending 31 March 2015 are expected to be ca. 9% ahead of the comparable period. The acquired businesses have contributed ca. 9% to Group revenues, but currency volatility has continued to impact the Group's results, reducing revenues by ca. 2%. On an underlying basis, after adjusting for the impact of currencies and acquisitions, revenues are expected to increase by ca. 2%.

 

The main driver to revenue growth has been from the Seals businesses where revenues have benefited both from acquisitions completed last year and from strong demand, particularly in the North American Seals businesses. In Life Sciences, the recent acquisition of the TPD business has contributed to a strong increase in headline revenues. Underlying growth has been flat as the Canadian Healthcare businesses have faced tougher markets, with hospitals increasing their focus on controlling costs as they approach the end of their budgetary fiscal year. In Controls, underlying revenues have reduced against the strong prior year comparative, reflecting lower activity in the Motorsport and Aerospace fastener sectors and softer European industrial markets.

 

Currency movements have continued to impact the Group's results on both a translational and transactional basis. Further depreciation against UK sterling, relative to last year, of the Euro and the Canadian and Australian dollars, more than offset the impact from the appreciation of the US dollar. The transactional impact from currency depreciation on the Life Sciences businesses has contributed to a slightly lower Group operating margin, as anticipated.

 

Financial Position

After spending ca. £34m on completing the acquisitions of TPD (Life Sciences) in October 2014 and Kubo (Seals) in early March 2015, the Group expects to have net debt of ca. £18m at 31 March 2015, compared with cash balances of £21.3m at 30 September 2014.

 

The Board will provide a further update on trading prospects for the year when the Group's Half Year's results are announced on Monday, 11 May 2015.

 

 

 

 

Note: A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

 

The Group employs ca. 1,300 employees and its principal operating businesses are located in the UK, Germany, US, Canada and Australia.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of 20% p.a. through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £900m.

 

 

Further information on Diploma PLC, together with a copy of this Announcement, is available at www.diplomaplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUWGWUPAGQM
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.